Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

61.91 USD -0.11 (-0.18%)
Streaming Delayed Price Updated: 6:15 AM EST, Jan 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Warren Buffett's 3 Biggest Stock Picks for 2021
Here's what the Oracle of Omaha is betting on for the coming year. 
Tags MRK JPM BRK/A
From Motley Fool
3 Reasons This Hot Stock May Not Survive 2021
This promising cancer fighter might sell out this year to cash in on its potential. 
Tags TRIL PFE Market News
From Motley Fool
3 Top Healthcare Stocks That Can Make You Richer in 2021 (and Beyond)
The future is bright for these three companies and investors who buy today could win big. 
Tags PRVL BMY LLY
From Motley Fool
3 Stocks Wall Street Thinks Will Soar 50% or More in 2021
These stocks have one obvious thing in common. 
Tags BMY Market News BLUE
From Motley Fool
Got $10,000? The 5 Best Stocks to Buy for a Biden Bull Market
Here's your roadmap to building wealth under the new administration. 
Tags Market News USB BRK/B
From Motley Fool
Exelixis Gets FDA Approval for Cabometyx in Combination Therapy for Front-Line RCC
The regulator's nod represents an important expansion for the drug. 
Tags BMY EXEL Market News
From Motley Fool
U.S. Food and Drug Administration Approves OPDIVO® (nivolumab) in Combination with CABOMETYX® (cabozantinib) as First-line Treatment for Patients with Advanced Renal Cell Carcinoma
US FDA Approves OPDIVO in Combination with CABOMETYX as First-line Treatment for Patients with Advanced Renal Cell Carcinoma 
From Business Wire News Releases
Bristol Myers Stock Is Eyeing A Buy Point At A 5-Year High — Is It A Buy?
Bristol Myers Squibb is poised for double-digit growth in 2020, thanks to its acquisition of Celgene. And, BMY stock is now trading near a five-year high. So, is BMY stock a buy? 
From Investor's Business Daily
2 Unstoppable Stocks to Buy With $1,000
Both have the potential to drive solid returns in 2021. 
Tags FB BMY Market News
From Motley Fool
Soap Opera
Proctor & Gamble is looking like it has topped. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Interesting BMY Put And Call Options For March 5th
Investors in Bristol Myers Squibb Co. (BMY) saw new options become available today, for the March 5th expiration.. 
Tags Stocks
From Market News Video
Notable ETF Inflow Detected - VIG, PEP, UNP, BMY
Symbols mentioned in this story: VIG, PEP, UNP, BMY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MRUS PROF INO
From Benzinga
Bristol Myers Squibb Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur on February 4, 2021 at 10 a.m. (Eastern Time)
Bristol Myers Squibb Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur on February 4, 2021 at 10 a.m. (Eastern Time) 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PASG JNJ ZLAB
From Benzinga
U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junc
US FDA Accepts for Priority Review Application for Opdivo Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer.... 
From Business Wire News Releases
U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer
U.S. FDA Accepts for Priority Review Application for Opdivo as Adjuvant Therapy for Patients w/Resected Esophageal or Gastroesophageal Junction Cancer 
From Business Wire News Releases
Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis Treatment
Can-Fite Biopharma Ltd. was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, ... 
Tags BMY Health Care Markets
From Benzinga
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
These drug approvals will help the smaller biotech co-developers. 
Tags BMY EXEL Market News
From Motley Fool
Grab Bristol Myers Squibb Before It Races Higher
This company steps into the needed role and provides the world with some of the very best drugs known to man. By doing so, they’re making a lot of money – and they’re sending out big and growing... 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances ... 
Tags MRNA Benzinga TLRY
From Benzinga
Bristol-Myers Squibb's Debt Overview
Over the past three months, shares of Bristol-Myers Squibb (NYSE: BMY) moved higher by 8.86%. Before having a look at the importance of ... 
Tags Market News Benzinga BZI/Debt
From Benzinga
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Those are some solid endorsements. 
Tags Market News NVTA RHHBY
From Motley Fool
Beigene Stock Breaks Out To Record High On Cancer Drug OK In China
Beigene stock broke out and surged to a record high Thursday after China's regulators approved its lung cancer treatment. Earlier this week, Novartis signed on to commercialize the drug. 
From Investor's Business Daily
Interesting BMY Put And Call Options For September 17th
Investors in Bristol Myers Squibb Co. (BMY) saw new options become available today, for the September 17th expiration.. 
Tags Stocks
From Market News Video
NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars
Clinical-stage immunotherapy company Nantkwest Inc NK reports positive interim data on survival rates in the Metastatic Pancreatic Cancer QUILT 88 trial on Wednesday. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars
Clinical-stage immunotherapy companyNantkwest Inc(NASDAQ: NK)reports positiveinterim data on survival rates in ... 
Tags General News Pancreatic Cancer
From Benzinga
3 Great Dividend Stocks That Are Simply Too Cheap to Ignore
High dividend yields plus low valuations could be just the ticket for income-seeking investors. 
Tags ABBV VTRS Market News
From Motley Fool
J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on... 
Tags ETFs Stocks / Equities Healthcare
From Blogs - TalkMarkets
SPLV, COST, BMY, EA: ETF Outflow Alert
Symbols mentioned in this story: SPLV, COST, BMY, EA Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.